Anti-Her-2 monoclonal antibody conjugated polymer fluorescent nanoparticles probe for ovarian cancer imaging

被引:24
|
作者
Hun, Xu [1 ,2 ]
Zhang, Zhujun [1 ]
Tiao, Liang [1 ]
机构
[1] Shaanxi Normal Univ, Sch Chem & Mat Sci, Dept Chem, Xian 710062, Peoples R China
[2] Xian Technol Univ, Sch Mat & Chem Engn, Xian 710032, Peoples R China
关键词
precipitation polymerization; polymer fluorescent nanoparticles (PFNPs); anti-Her-2 monoclonal antibody; ovarian cancer; fluorescence microscopy imaging;
D O I
10.1016/j.aca.2008.07.038
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Fluorescent nanoparticles (FNPs) with unique optical properties may be useful as biosensors in living cancer cell imaging and cancer targeting. A novel kind of polymer fluorescent nanoparticles (PFNPs) was synthesized and its application for ovarian cancer imaging with fluorescence microscopy imaging technology was presented in this study. The PFNPs were synthesized with precipitation polymerization by using methacrylic acid (MAA) as monomer, trimethylolpropane trimethacrylate (Trim) as cross-linker, azobisisobutyronitrile (AIBN) as radical initiator and butyl rhodamine B (BTRB) as fluorescent dye. And the fluorescent dye was embedded into the three-dimensional network of the polymer when the polymer was produced. With this method the PFNPs can be prepared easily. And then the PFNPs were successfully modified with anti-Her-2 monoclonal antibody. The fluorescence probe based on anti-Her-2 monoclonal antibody conjugated PFNPs has been used to detect ovarian cancer cells with fluorescence microscopy imaging technology. The experimental results demonstrate that the anti-Her-2 monoclonal antibody conjugated PFNPs can effectively recognize ovarian cancer cells and exhibit good sensitivity and exceptional photostability, which would provide a novel way for the diagnosis and curative effect observation of ovarian cancer cells. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:201 / 206
页数:6
相关论文
共 50 条
  • [21] Anti-HER-2 antibody inhibits COX-2 expression and reduces survival of human colon cancer cells.
    Half, E
    Sun, YJ
    Sinicrope, FA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1195S - 1195S
  • [22] Anti-HER-2 engineered antibody chA21 inhibits growth and induces apoptosis of human ovarian cancer cell SKOV 3 in vitro.
    Wu, Q.
    Xue, H.
    Ling, X. -G.
    Cheng, L. -S.
    Liu, J.
    SHOCK, 2006, 26 : 27 - 27
  • [23] Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models
    Agus, DB
    Scher, HI
    Higgins, B
    Fox, WD
    Heller, G
    Fazzari, M
    Cordon-Cardo, C
    Golde, DW
    CANCER RESEARCH, 1999, 59 (19) : 4761 - 4764
  • [24] TARGETED PHOTODESTRUCTION OF OVARIAN CANCER CELLS USING ANTI-HER2 CONJUGATED ICG-LOADED POLYMERIC NANOPARTICLES
    Bahmani, Baharak
    Anvari, Bahman
    LASERS IN SURGERY AND MEDICINE, 2013, 45 : 38 - 38
  • [25] Adjuvant anti-HER2 monoclonal antibody therapy - ready for breast cancer?
    Perez, EA
    BREAST, 2001, 10 : 161 - 163
  • [26] Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer
    Albanell, J
    Baselga, J
    DRUGS OF TODAY, 1999, 35 (12): : 931 - 946
  • [27] Anti-HER2 monoclonal antibody therapy with adjuvant chemotherapy for breast cancer
    Perez, Edith A.
    ANNALS OF ONCOLOGY, 2006, 17 : 39 - 39
  • [28] A fluorescent probe for imaging hydrogen peroxide in ovarian cancer cells
    Zhao, Peng
    Wang, Kunyan
    Zhu, Xiaomin
    Zhou, Yuren
    Wu, Junchen
    DYES AND PIGMENTS, 2018, 155 : 143 - 149
  • [29] MR molecular imaging of HER-2 in a murine tumor xenograft by SPIO labeling of anti-HER-2 affibody
    Kinoshita, Manabu
    Yoshioka, Yoshichika
    Okita, Yoshiko
    Hashimoto, Naoya
    Yoshimine, Toshiki
    CONTRAST MEDIA & MOLECULAR IMAGING, 2010, 5 (01) : 18 - 22
  • [30] HER2 monoclonal antibody conjugated RNase-A-associated CdTe quantum dots for targeted imaging and therapy of gastric cancer
    Ruan, Jing
    Song, Hua
    Qian, Qirong
    Li, Chao
    Wang, Kan
    Bao, Chenchen
    Cui, Daxiang
    BIOMATERIALS, 2012, 33 (29) : 7093 - 7102